Filtered By:
Infectious Disease: COVID-19

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 5132 results found since Jan 2013.

High anxiety and health-related quality-of-life in families with children with food allergy during COVID-19.
CONCLUSION: Mothers with food allergic children reported high anxiety and poor HRQL. Yet, qualitatively, day-to-day food allergy management was better during the pandemic. PMID: 32950685 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - September 16, 2020 Category: Allergy & Immunology Authors: Protudjer JLP, Golding M, Salisbury MR, Abrams EM, Roos LE Tags: Ann Allergy Asthma Immunol Source Type: research

Drug allergy management in the elderly
Purpose of review Drug allergy management has previously not been emphasized in the elderly. However, the geriatric population poses several unique characteristics, challenges for drug allergy testing and considerations in the management. Especially in the era of COVID-19, the elderly population is a vulnerable cohort and reviewing the management during this unprecedented time is both timely and relevant. Recent findings In recent years, larger scale studies focusing on the epidemiology and prevalence trends of drug allergies among older adults has been summarized in this review. Emphasis on anaphylaxis in the o...
Source: Current Opinion in Allergy and Clinical Immunology - July 14, 2021 Category: Allergy & Immunology Tags: DRUG ALLERGY: Edited by Miguel Blanca and Paul Whitaker Source Type: research

Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease
Aimmune Therapuetics said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to patients as allergy specialists reopen, the drugmaker ' s executives told Reuters on Thursday.Reuters Health Information
Source: Medscape Allergy Headlines - July 6, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Most Care at Allergy Clinics Could Be Postponed During COVID-19 Most Care at Allergy Clinics Could Be Postponed During COVID-19
Most allergy and immunology care could be postponed or handled virtually during the COVID-19 pandemic, according to consensus-based recommendations.Reuters Health Information
Source: Medscape Allergy Headlines - April 3, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Harsh Spring Allergy Season Spurs Hay Fever Fears Harsh Spring Allergy Season Spurs Hay Fever Fears
A consistent increase in the intensity and length of allergy season in regions of the United States signals a difficult season in 2020, at the same time as the COVID-19 pandemic affects communities.Medscape Medical News
Source: Medscape Allergy Headlines - April 4, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Don ' t Endanger Your Patients: Stop Allergy Immunotherapy Now Don ' t Endanger Your Patients: Stop Allergy Immunotherapy Now
A medical society recently published recommendations to continue allergen immunotherapy during the COVID-19 pandemic. Is this the right decision?Medscape Allergy & Immunology
Source: Medscape Allergy Headlines - April 6, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Viewpoint Source Type: news

Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know.
PMID: 32448437 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - May 27, 2020 Category: Allergy & Immunology Authors: Castells MC Tags: Ann Allergy Asthma Immunol Source Type: research

From Parkinson ' s to Peanut Allergy, Pandemic Puts Brakes on New Drugs From Parkinson ' s to Peanut Allergy, Pandemic Puts Brakes on New Drugs
Treatments for peanut allergy and Parkinson ' s disease are among U.S. drug launches that have been postponed by the COVID-19 pandemic as drugmakers struggle with disruptions to business, a Reuters review of filings and interviews with executives show.Reuters Health Information
Source: Medscape Allergy Headlines - July 2, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019.
PMID: 32859351 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - August 30, 2020 Category: Allergy & Immunology Authors: Ciprandi G, Licari A, Filippelli G, Tosca MA, Marseglia GL Tags: Ann Allergy Asthma Immunol Source Type: research

U.S. Public Health Resources for COVID-19 That Are Relevant to Allergy/Immunology.
PMID: 32858238 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - August 24, 2020 Category: Allergy & Immunology Authors: Hsu J Tags: Ann Allergy Asthma Immunol Source Type: research

Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
PMID: 33493641 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - January 22, 2021 Category: Allergy & Immunology Authors: Murphy KR, Patel NC, Ein D, Hudelson M, Kodoth S, Marshall GD, Parikh P, Blaiss MS Tags: Ann Allergy Asthma Immunol Source Type: research

Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada
CONCLUSION: This is the first study to estimate the prevalence of vaccine and PEG allergy in a national cohort that utilizes PCP documentation, demonstrating a low reported rate of vaccine allergy and PEG allergy.PMID:34004274 | DOI:10.1016/j.anai.2021.05.011
Source: Annals of Allergy, Asthma and Immunology - May 18, 2021 Category: Allergy & Immunology Authors: Elissa M Abrams Matthew Greenhawt Marcus Shaker Leanne Kosowan Alexander G Singer Source Type: research

Change in Allergy Practice during the COVID-19 Pandemic
Conclusions: Allergists in Turkey have been using telemedicine at a high rate during the COVID-19 pandemic for asthma and rhinitis. The continuation rate of SCIT was low while the discontinuation rate of biologicals and systemic steroid use in asthma was high in Turkey.Our study results and learning from the experiences of other countries and specialties may help to optimize allergy practice and compatibility with international guidelines.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - October 15, 2020 Category: Allergy & Immunology Source Type: research

Assessment of current practice of paediatric respiratory and allergy teams in Cambridge University Hospital during the COVID-19 pandemic era and optimisation of the service
Introduction: The paediatric respiratory and allergy teams in Cambridge Hospital see patients with atopic and overlapping conditions, thus increasing travel for patients and hospital footfall. It is a tertiary reference hospital covering East England. Assessment of practice and changes of the service, in view of COVID-19 pandemic.Method: Retrospective assessment of patients: a) referred between the specialties (1/4/19- 31/3/20), investigations booked (lung function, skin prick testing, specific IgE, peak flow, inhaler and nasal spray technique) and patient flow. b) currently being seen by both teams (1/4/18-31/3/20).R...
Source: European Respiratory Journal - November 25, 2021 Category: Respiratory Medicine Authors: Powell, E., Nethercott, S., Ali, A., Wilson, G., Zolkipli, Z., Mcshane, D., Kotzia, D. Tags: Paediatric asthma and allergy Source Type: research

Paediatric allergy practice in the era of coronavirus disease 2019
Purpose of review To summarize the impact of the COVID-19 pandemic on the practice of paediatric allergy. Recent findings Given significant overlap in symptoms, care must be taken to differentiate routine allergic conditions from COVID-19 infection but it appears that most allergic diseases are not risk factors for a severe COVID-19 course. The full impact of restricted allergy/immunology ambulatory services will take months to years to fully understand. One benefit of having to adapt practice style is greater awareness and acceptance of shared decision-making and recognition of preference-sensitive care options...
Source: Current Opinion in Allergy and Clinical Immunology - March 3, 2021 Category: Allergy & Immunology Tags: PEDIATRIC ASTHMA AND DEVELOPMENT OF ATOPY: Edited by Andy Liu and Pasquale Comberiati Source Type: research